Observer-masked trial comparing efficacy of topical olopatadine (0.1 & #37;), bepotastine (1.5 & #37;), and alcaftadine (0.25 & #37;) in mild to moderate allergic conjunctivitis
Conclusion: We concluded similar efficacy of three medications in relieving symptoms and inefficacy in regressing palpebral and limbal papillae in cases of allergic conjunctivitis.
Source: Indian Journal of Ophthalmology - Category: Opthalmology Authors: Lakshey Dudeja Anuja Janakiraman Ishani Dudeja Kaustubh Sane Manohar Babu Source Type: research
More News: Allergy & Immunology | Clinical Trials | Conjunctivitis | Environmental Health | India Health | Opthalmology | Study